In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Biomarkers Study group

of the Acute Cardiovascular Care Association

Founded by Prof. Kristian Thygesen, and now chaired by Prof. Bertil Lindhal, this group of experts is focusing on the proper clinical application of cardiac biomarkers including troponins, natriuretic peptides, and inflammatory and thrombotic markers in acute cardiac care.

Interested in advancing the biomarkers science? Apply to be part of the group.

Deadline 20 May 2018


  • To disseminate knowledge about proper clinical application of cardiac biomarkers in acute cardiac care. 
  • To advise on appropriate application of biomarkers in cardiovascular research. 
  • To promote opportunities for composing guidelines for implementation of cardiac biomarkers in acute cardiac care.
  • To be a counseling source for authorities regarding appropriate clinical use of cardiac biomarkers.

Recent publications

Study group leadership


Bertil Lindhal (SW)


Kristian Thygesen (DE)
(study group founder)

Study group members

  • Alan Jaffe - USA
  • Christian Mueller - CH
  • Johannes Mair - AT
  • Kurt Huber - AT
  • Martin Moeckel - GE
  • Evangelos Giannitsis - GE

NEW - Call for new member

We welcome the application of candidates who:
• Are ACCA paying members (Ivory, Silver or Gold) - JOIN ACCA
• Have contributed substantially to the field of biomarkers with multiple original scientific papers published in top journals
• Have a documented interest in education issues in the field
• Provide complimentary expertise to the current members

The application should be sent electronically via eform and contain the following:
1. A motivation letter describing the applicant’s expertise in the field of biomarkers, and what the applicant thinks she/he would contribute to the group (maximum 1 page).
2. An up-to-date CV that provides information on the applicant’s education, positions held, grants, educational experience and professional activities.
3. An up-to-date list of published peer-reviewed original and review articles.
4. Copies of the applicant’s five most relevant articles in the field of biomarkers.

In order to increase the representation of female scientists in the ESC ACCA study groups, a female candidate would be preferred in case of identical qualification as to a male candidate.

Deadline for the application is 20 May 2018


Previous publications


2014 - 2015